Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
J Gynecol Obstet Hum Reprod ; 46(3): 275-283, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28403926

ABSTRACT

OBJECTIVES: This study aims to describe how microarray comparative genomic hybridization (aCGH) has shifted to become a prenatal diagnosis tool at the Lyon university-hospital. MATERIALS AND METHODS: This retrospective study included all patients who were referred in the 3 pluridisciplinary centers for prenatal diagnosis of the Lyon university-hospital and who received a prenatal aCGH between June 2013 and June 2015. aCGH was systematically performed in parallel with a karyotype, using the PréCytoNEM array design. RESULTS: A total of 260 microarrays were performed for the following indications: 249 abnormal ultrasounds (95.8%), 7 characterizations of chromosomal rearrangements (2.7%), and 4 twins with no abnormal ultrasounds (1.5%). With a resolution of 1 mega base, we found 235 normal results (90.4%), 23 abnormal results (8.8%) and 2 non-returns (0.8%). For the chromosomal rearrangements visible on the karyotype, aCGH identified all of the 12 unbalanced rearrangements and did not identify the 2 balanced rearrangements. Among the fetuses with normal karyotypes, 11 showed abnormal microarray results, corresponding to unbalanced cryptic chromosomal rearrangements (4.2%). CONCLUSION: Transferring aCGH to a prenatal diagnosis at the Lyon university-hospital has increased the detection rate of chromosomal abnormalities by 4.2% compared to the single karyotype.


Subject(s)
Chromosome Aberrations , Chromosome Disorders/diagnosis , Comparative Genomic Hybridization , Prenatal Diagnosis , Adolescent , Adult , Female , France , Hospitals, University , Humans , Pregnancy , Retrospective Studies , Young Adult
2.
Ultrasound Obstet Gynecol ; 50(5): 635-641, 2017 Nov.
Article in English | MEDLINE | ID: mdl-27804180

ABSTRACT

OBJECTIVE: To demonstrate the feasibility and efficacy of high-intensity focused ultrasound (HIFU) for the non-invasive creation of placental lesions in a simian model. METHODS: Eight pregnant monkeys were exposed to HIFU treatment after anesthesia, using a toroidal HIFU 2.5-MHz transducer with an integrated ultrasound imaging probe. Lesions on the placental tissue were created non-invasively by placing the HIFU probe on the skin surface. Fetal and maternal parameters, such as maternal heart rate, fetal heart rate and subcutaneous and intra-amniotic fluid temperature, were recorded during HIFU exposure. Cesarean section was performed immediately after the procedure to extract the placenta and examine the fetus and the maternal abdominal cavity. Placental HIFU lesions were assessed by ultrasound, gross pathology and histology. RESULTS: The mean gestational age of the monkeys was 72 ± 4 days. In total, 13 HIFU procedures were performed. The acoustic power and exposure time were increased progressively. This gradual increase in total energy delivered was used to determine a set of parameters to create reproducible lesions in the placenta without complications. Five placental lesions were observed with average diameters of 6.4 ± 0.5 mm and 7.8 ± 0.7 mm and an average depth of 3.8 ± 1.5 mm. Ultrasound examination of the placentae revealed hyperechoic regions that correlated well with macroscopic analysis of the HIFU lesions. Necrosis of placental tissue exposed to HIFU was confirmed with macroscopic and microscopic analysis. There was no significant variation in maternal and fetal parameters during HIFU exposure. CONCLUSIONS: This study demonstrates the feasibility of HIFU applied non-invasively to the placental unit in an in-vivo pregnant monkey model. The technique is safe in the immediate short term and is potentially translatable to human pregnancy. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.


Subject(s)
Extracorporeal Shockwave Therapy/methods , Placenta Diseases/therapy , Ultrasonography, Prenatal/methods , Animals , Feasibility Studies , Female , Gestational Age , Haplorhini , Models, Animal , Placenta Diseases/etiology , Pregnancy , Treatment Outcome
3.
J Gynecol Obstet Biol Reprod (Paris) ; 45(5): 521-4, 2016 May.
Article in French | MEDLINE | ID: mdl-27021927

ABSTRACT

Pregnancy in a rudimentary horn of a pseudo-horned uterus is a rare obstetrical situation, for which, maternal-fetal prognosis is altered by the risk of uterine rupture. We report a rare case of pregnancy in a rudimentary horn with birth of a living child at 28 weeks of amenorrhea. During caesarean, uterine rupture plugged by the omentum was observed. We discuss from this case obstetric management of this pathology.


Subject(s)
Omentum , Pregnancy Complications , Uterine Rupture , Uterus/abnormalities , Adult , Cesarean Section , Female , Fetal Development , Fetal Organ Maturity/drug effects , Gestational Age , Humans , Lung/embryology , Pregnancy , Prognosis , Risk Factors , Ultrasonography, Prenatal , Uterine Rupture/surgery , Uterus/diagnostic imaging , Uterus/surgery
4.
Gynecol Obstet Fertil ; 44(2): 106-12, 2016 Feb.
Article in French | MEDLINE | ID: mdl-26850282

ABSTRACT

Epidemiological studies have shown a relationship between endometriosis and clear cell/endometrioid ovarian cancers (named "Endometriosis Associated Ovarian Cancer" or EAOC). The recent discovery of signaling pathways (especially the SWI/SNF and PI3K/AKT/mTOR pathways) that linked endometriosis and EAOC could lead to the development of specific biomarkers as ARID1A to screen benign to premalignant endometriosis and to new targeted treatment. Moreover, the better understanding of the pathogenesis of the epithelial ovarian cancer arising from the Fallopian tube could allow new early prevention strategies that will be described in this review.


Subject(s)
Endometriosis , Ovarian Neoplasms , Precancerous Conditions , Adenocarcinoma, Clear Cell , Biomarkers , Carcinoma, Endometrioid , DNA-Binding Proteins , Endometriosis/epidemiology , Endometriosis/pathology , Female , Genetic Predisposition to Disease , Humans , Neoplasm Staging , Nuclear Proteins , Ovarian Neoplasms/epidemiology , Ovarian Neoplasms/genetics , Ovarian Neoplasms/pathology , Signal Transduction , Transcription Factors
5.
Ultrasound Obstet Gynecol ; 45(3): 313-9, 2015 Mar.
Article in English | MEDLINE | ID: mdl-24723334

ABSTRACT

OBJECTIVE: To demonstrate in an ex-vivo model the feasibility of applying high-intensity focused ultrasound (HIFU) using a toroidal transducer for the creation of placental lesions. METHODS: In this study we used a toroidal transducer, composed of 32 ring-shaped emitters with an ultrasound probe at the center, operating at a frequency of 2.5 MHz. We examined 45 human placentae, following either normal vaginal delivery or medical termination of pregnancy between 17 and 40 gestational weeks. First, the attenuation coefficients of 12 human placentae were measured and integrated into a numerical model for simulating HIFU lesions. Then, using acoustic parameters from this preliminary study, we performed ex-vivo experiments with 33 human placentae, each overlain with an animal abdominal wall to simulate the maternal wall. We created single HIFU lesions in 25 of these placentae, and a series of six juxtaposed lesions in eight, studying these both sonographically and macroscopically. RESULTS: Human placental attenuation coefficients of the 12 human placentae ranged from 0.072 to 0.098 Np/cm/MHz, according to gestational age. The 25 single HIFU lesions created had an average diameter of 7.1 ± 3.2 mm and an average depth of 8.2 ± 3.1 mm. The average diameter of the eight series of six juxtaposed HIFU lesions was 23.0 ± 5.0 mm and the average depth was 11.0 ± 4.7 mm. The average thickness of the abdominal walls was 10.5 ± 1.8 mm. No lesions or damage were observed in intervening tissues. CONCLUSION: This study demonstrates, using an ex-vivo model, the feasibility, reproducibility, harmlessness and effectiveness of HIFU applied to the human placenta.


Subject(s)
High-Intensity Focused Ultrasound Ablation , Placenta/pathology , Equipment Design , Feasibility Studies , Female , Humans , Pregnancy , Reproducibility of Results
6.
Gynecol Obstet Fertil ; 39(12): e77-80, 2011 Dec.
Article in French | MEDLINE | ID: mdl-22079744

ABSTRACT

We report a rare case of true false negative of chorionic villi sampling for a child with Down syndrome. A chorionic villi sampling was performed for a nuchal translucency at the first trimester. The karyotype was 46,XX for the short and the long-term culture. Because of facial dysmorphy and cardiopathy to the child, a karytoype was proposed. This postnatal karyotype showed a trisomy 21, by isochromosome 46,XX,i(21)(q10). We expose the mechanism of true false negative of chorionic villi sampling, and particularly the role of isochromosome in this case.


Subject(s)
Chorionic Villi Sampling , Down Syndrome/diagnosis , Down Syndrome/genetics , Isochromosomes , False Negative Reactions , Female , Humans , Pregnancy , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...